Jade Biosciences Inc. (AVTE)
NASDAQ · Healthcare
Jade Biosciences Inc. Shareholder Equity 2019–2024
Jade Biosciences Inc. annual shareholder equity history from 2019 to 2024. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Jade Biosciences Inc. shareholder equity as of December 31, 2024: 76.4M, a 30.17% decrease year-over-year.
- Jade Biosciences Inc. shareholder equity for 2024 were 76.4M, a 30.17% decrease from 2023.
- Jade Biosciences Inc. shareholder equity for 2023 were 109.5M, a 13.64% decrease from 2022.
- Jade Biosciences Inc. shareholder equity for 2022 were 126.7M, a 26.49% decrease from 2021.
- Jade Biosciences Inc. shareholder equity for 2021 were 172.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Jade Biosciences Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2024 | $76 |
| 2023 | $109 |
| 2022 | $127 |
| 2021 | $172 |
| 2020 | $-13 |
| 2019 | $-4 |
Jade Biosciences Inc. Shareholder Equity — FAQ
Jade Biosciences Inc. (AVTE) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVTE's shareholder equity history?
The chart and table above show Jade Biosciences Inc.'s shareholder equity by year and by quarter, including the growth rate.